JCI Insight (May 2022)

Hem-1 regulates protective humoral immunity and limits autoantibody production in a B cell–specific manner

  • Alan Avalos,
  • Jacob T. Tietsort,
  • Nutthakarn Suwankitwat,
  • Jonathan D. Woods,
  • Shaun W. Jackson,
  • Alexandra Christodoulou,
  • Christopher Morrill,
  • H. Denny Liggitt,
  • Chengsong Zhu,
  • Quan-Zhen Li,
  • Kevin K. Bui,
  • Heon Park,
  • Brian M. Iritani

Journal volume & issue
Vol. 7, no. 9

Abstract

Read online

Hematopoietic protein-1 (Hem-1) is a member of the actin-regulatory WASp family verprolin homolog (WAVE) complex. Loss-of-function variants in the NCKAP1L gene encoding Hem-1 were recently discovered to result in primary immunodeficiency disease (PID) in children, characterized by poor specific Ab responses, increased autoantibodies, and high mortality. However, the mechanisms of how Hem-1 deficiency results in PID are unclear. In this study, we utilized constitutive and B cell–specific Nckap1l-KO mice to dissect the importance of Hem-1 in B cell development and functions. B cell–specific disruption of Hem-1 resulted in reduced numbers of recirculating follicular (FO), marginal zone (MZ), and B1 B cells. B cell migration in response to CXCL12 and -13 were reduced. T-independent Ab responses were nearly abolished, resulting in failed protective immunity to Streptococcus pneumoniae challenge. In contrast, T-dependent IgM and IgG2c, memory B cell, and plasma cell responses were more robust relative to WT control mice. B cell–specific Hem-1–deficient mice had increased autoantibodies against multiple autoantigens, and this correlated with hyperresponsive BCR signaling and increased representation of CD11c+T-bet+ age-associated B cell (ABC cells) — alterations associated with autoimmune diseases. These results suggest that dysfunctional B cells may be part of a mechanism explaining why loss-of-function Hem-1 variants result in recurring infections and autoimmunity.

Keywords